Lopci E - Search Results

1

Metabolism of Stem and Progenitor Cells: Proper Methods to Answer Specific Questions.

Martano G, Borroni EM, Lopci E, Cattaneo MG, Mattioli M, Bachi A, Decimo I, Bifari F. Martano G, et al. Among authors: lopci e. Front Mol Neurosci. 2019 Jun 13;12:151. doi: 10.3389/fnmol.2019.00151. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31249511 Free PMC article. Review.

2

High-dimensional single cell analysis identifies stem-like cytotoxic CD8⁺ T cells infiltrating human tumors.

Brummelman J, Mazza EMC, Alvisi G, Colombo FS, Grilli A, Mikulak J, Mavilio D, Alloisio M, Ferrari F, Lopci E, Novellis P, Veronesi G, Lugli E. Brummelman J, et al. Among authors: lopci e. J Exp Med. 2018 Oct 1;215(10):2520-2535. doi: 10.1084/jem.20180684. Epub 2018 Aug 28. J Exp Med. 2018. PMID: 30154266 Free PMC article.

3

Update on tumor metabolism and patterns of response to immunotherapy.

Castello A, Lopci E. Castello A, et al. Among authors: lopci e. Q J Nucl Med Mol Imaging. 2020 Jun;64(2):175-185. doi: 10.23736/S1824-4785.20.03251-3. Epub 2020 Feb 27. Q J Nucl Med Mol Imaging. 2020. PMID: 32107904 Free article. Review.

4

Comparison of Metabolic and Morphological Response Criteria for Early Prediction of Response and Survival in NSCLC Patients Treated With Anti-PD-1/PD-L1.

Castello A, Rossi S, Toschi L, Lopci E. Castello A, et al. Among authors: lopci e. Front Oncol. 2020 Jul 31;10:1090. doi: 10.3389/fonc.2020.01090. eCollection 2020. Front Oncol. 2020. PMID: 32850315 Free PMC article.

5

Editorial: Response assessment of radioligand therapies.

Lopci E, Prasad V. Lopci E, et al. Front Oncol. 2022 Jul 27;12:904337. doi: 10.3389/fonc.2022.904337. eCollection 2022. Front Oncol. 2022. PMID: 35965585 Free PMC article. No abstract available.

6

The Complexity and Fractal Geometry of Nuclear Medicine Images.

Grizzi F, Castello A, Qehajaj D, Russo C, Lopci E. Grizzi F, et al. Among authors: lopci e. Mol Imaging Biol. 2019 Jun;21(3):401-409. doi: 10.1007/s11307-018-1236-5. Mol Imaging Biol. 2019. PMID: 30003453 Review.

7

In-vivo imaging of methionine metabolism in patients with suspected malignant pleural mesothelioma.

Lopci E, Novellis P, Testori A, Rahal D, Voulaz E, Bottoni E, Ferraroli GM, Crepaldi A, Ceresoli GL, Perrino M, Castello A, Alloisio M, Veronesi G, Zucali PA. Lopci E, et al. Nucl Med Commun. 2019 Nov;40(11):1179-1186. doi: 10.1097/MNM.0000000000001078. Nucl Med Commun. 2019. PMID: 31568271 Clinical Trial.

8

Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography.

Oprea-Lager DE, Cysouw MCF, Boellaard R, Deroose CM, de Geus-Oei LF, Lopci E, Bidaut L, Herrmann K, Fournier LS, Bäuerle T, deSouza NM, Lecouvet FE. Oprea-Lager DE, et al. Among authors: lopci e. Front Oncol. 2021 Nov 19;11:772530. doi: 10.3389/fonc.2021.772530. eCollection 2021. Front Oncol. 2021. PMID: 34869009 Free PMC article. Review.

9

PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Lopci E, Grassi I, Chiti A, Nanni C, Cicoria G, Toschi L, Fonti C, Lodi F, Mattioli S, Fanti S. Lopci E, et al. Am J Nucl Med Mol Imaging. 2014 Jun 7;4(4):365-84. eCollection 2014. Am J Nucl Med Mol Imaging. 2014. PMID: 24982822 Free PMC article. Review.

10

Is it time to change our vision of tumor metabolism prior to immunotherapy?

Grizzi F, Castello A, Lopci E. Grizzi F, et al. Among authors: lopci e. Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1072-1075. doi: 10.1007/s00259-018-3988-1. Epub 2018 Mar 12. Eur J Nucl Med Mol Imaging. 2018. PMID: 29532102 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page